Looking to list your PhD opportunities? Log in here.
This project is no longer listed on FindAPhD.com and may not be available.
Click here to search FindAPhD.com for PhD studentship opportunitiesAbout the Project
The devastating world-wide effects of Covid19 have highlighted the threat posed by viruses with the potential to cause epidemics and pandemics. It is important that effective therapeutics and detection reagents are developed for such viruses. We have recently used protein engineering and directed evolution techniques to create antagonists and traps (decoys) to block Covid19 virus infectivity, and for use as novel diagnostics.
This project will use similar molecular approaches to develop biotherapeutics and diagnostics for viruses that have been prioritized by the WHO as having epidemic and pandemic potential and for which there are currently no effective treatments. Directed evolution and protein engineering will also be used to optimize vaccine candidates for such viruses. The student will receive advanced trained in a range of techniques including molecular biology, protein engineering, mammalian cell surface display, directed protein evolution, protein expression and characterization, flow cytometry, FACS and cryo-electron microscopy.
Entry requirements:
Applicants should have or expect to obtain a first or upper second class honours degree (or equivalent) in an appropriate subject.
The University of Leicester English language requirements apply where applicable: https://le.ac.uk/study/research-degrees/entry-reqs/eng-lang-reqs/ielts-65
How to apply:
Initial enquiries to Prof. N Brindle ([Email Address Removed]).
References
2. Brindle, N. P., J. E. Sale, H. Arakawa, J. M. Buerstedde, T. Nuamchit, S. Sharma and K. H. Steele (2013). "Directed Evolution of an Angiopoietin-2 Ligand Trap by Somatic Hypermutation and Cell Surface Display." J Biol Chem 288: 33205-33212.
3. Fischer, M., M. Kang and N. P. Brindle (2016). "Using experimental evolution to probe molecular mechanisms of protein function." Protein Sci 25(2): 352-359.
4. Issa, E., A. J. Moss, M. Fischer, M. Kang, S. Ahmed, H. Farah, N. Bate, D. Giakomidi and N. P. Brindle (2018). "Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2." Mol Pharm 15: 3962-3968.
How good is research at University of Leicester in Clinical Medicine?
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universities
Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leicester, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
University of Greenwich
Process Development for New Formulation Products with Nanoparticles
Loughborough University
Development of New fuels Assemblies for Advanced Nuclear Technologies
The University of Manchester